Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Kenneth R Carson"'
Autor:
Shamia Hoque, Brian J Chen, Martin W Schoen, Kenneth R Carson, Jesse Keller, Bartlett J Witherspoon, Kevin B Knopf, Y Tony Yang, Benjamin Schooley, Chadi Nabhan, Oliver Sartor, Paul R Yarnold, Paul Ray, Laura Bobolts, William J Hrushesky, Michael Dickson, Charles L Bennett
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234541 (2020)
Erythropoisis stimulating agent (ESA) use was addressed in Food and Drug Administration (FDA) Oncology Drug Advisory Committee (ODAC) meetings between 2004 and 2008. FDA safety-focused regulatory actions occurred in 2007 and 2008. In 2007, black box
Externí odkaz:
https://doaj.org/article/db22cc567bfb42b08476116e945c2620
Autor:
Kasey A Reynolds, Natalia M Grindler, Julie S Rhee, Amber R Cooper, Valerie S Ratts, Kenneth R Carson, Emily S Jungheim
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127335 (2015)
Fertility is important to women and men with cancer. While options for fertility preservation (FP) are available, knowledge regarding the medical application of FP is lacking. Therefore we examined FP practices for cancer patients among reproductive
Externí odkaz:
https://doaj.org/article/d3de60c5201b46dfbbf40a2b3d6419c5
Autor:
Kristen M. Sanfilippo, Kenneth R. Carson, Tzu‐Fei Wang, Suhong Luo, Natasha Edwin, Nicole Kuderer, Jesse M. Keller, Brian F. Gage
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)
Abstract Background Guidelines recommend thromboprophylaxis for patients with multiple myeloma (MM) at high risk for venous thromboembolism (VTE). However, the optimal risk prediction model for VTE in MM remains unclear. Khorana et al developed a VTE
Externí odkaz:
https://doaj.org/article/113ae2b1ee5345e4ad565ab4976b3933
Autor:
Norihiko Oharu, Patrick Schnell, Keith D. Wilner, Jack Mardekian, Michelle Yu-Kite, Diane D. Wang, Jillian Motyl Rockland, Dongrui R. Lu, Todd VanArsdale, Jennifer M. Tursi, Albert L. Kraus, Cynthia Huang Bartlett, Matthew J. Cotter, Kenneth R. Carson, Jaclyn Decembrino, Sindy T. Kim, Anala Gossai, Tamara Snow
Publikováno v:
Clinical Pharmacology & Therapeutics. 111:302-309
This report examined the benefits and risks of palbociclib plus endocrine therapy (ET) in men with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC). Palbociclib was evaluated usi
Publikováno v:
Cancer treatment and research. 184
More than half of all serious adverse drug reactions are identified seven years after FDA approval. One recent and unusual example involves a syndrome initially termed nephrogenic dermatopathic fibrosis, and then called nephrogenic systemic fibrosis
Publikováno v:
Cancer treatment and research. 184
Progressive multifocal leukoencephalopathy (PML) is a John-Cunningham virus-related central nervous system that is rarely observed in persons treated with the anti-CD20 monoclonal antibody, rituximab.
Autor:
Martin W. Schoen, Kenneth R. Carson, Seth A. Eisen, Charles L. Bennett, Suhong Luo, Melissa A. Reimers, Eric M. Knoche, Alison L. Whitmer, Yan Yan, Bettina F. Drake, Kristen M. Sanfilippo
Publikováno v:
Prostate Cancer and Prostatic Diseases.
Background Comorbid diseases influence patient outcomes, yet little is known about how comorbidities interact with treatments for metastatic castrate-resistant prostate cancer (mCRPC). No head-to-head trials have compared the efficacy of abiraterone
Autor:
Carlos Chiattone, Monica Civallero, Thais Fischer, Eliana Miranda, Martina Manni, Natalia P. C. Zing, Stefano A. Pileri, Silvia Montoto, Steven M. Horwitz, Maria Elena Cabrera, Carmino A. De Souza, Arnon Nagler, Stefano Luminari, Andrés J. M. Ferreri, Kenneth R. Carson, Alessandro Re, Luigi Rigacci, Luca Nassi, Yana Stepanishyna, Massimo Federico, Giorgio Inghirami
Publikováno v:
Hematological oncologyREFERENCES.
The T-cell Lymphoma Project is an international registry prospective study that enrolled patients with newly diagnosed peripheral T-cell and NK-cell lymphomas (PTCL). The main objective was to define the clinical features and outcomes, establishing a
Autor:
Siraj M. Ali, Junya Fujimoto, Elad Sharon, Garrett M. Frampton, Kathleen Maignan, Aracelis Z. Torres, Gerald Li, Ignacio I. Wistuba, Vinodh N. Rajapakse, Jeremy Snider, Eva Szabo, Camille Tlemsani, Nobuyuki Takahashi, Javed Khan, Samantha Nichols, Anish Thomas, Jun Wei, Se Hyun Kim, Kenneth R. Carson, Idrees Mian, Udayan Guha, Cesar A Moran, Lorinc Pongor
Publikováno v:
Chest. 158:1723-1733
Background Small cell lung cancer (SCLC) has the strongest association with smoking among lung cancers. The characteristics of never smokers with SCLC is not known. Research Question Are the clinical characteristics, prognostic factors, survival, gen
Autor:
Kenneth R. Carson, Suhong Luo, Bettina F. Drake, Su-Hsin Chang, Adetunji T. Toriola, Kristen M. Sanfilippo, Theodore S. Thomas
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: The effect of metformin use on survival among patients with pancreatic ductal adenocarcinoma (PDAC) is controversial. Furthermore, there are no data on African American patients. To address these, we analyzed data from the United States V